The U.S. will impose tariffs of up to 100% on branded pharmaceuticals, though countries or drugmakers that strike deals with the Trump administration can receive lower levies or none at all

Drugmakers or countries that strike pricing deals or make manufacturing investment commitments in the U.S. can secure much lower levies, or none at all.



Source link

About The Author

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top